References,Sample size,Interventions,Main race,Female (%),Mean HAMA,Mean age (Year),Attrition rate (%),Sponsor,Follow-up time (weeks),Diagnosis criteria
"Montgomery et al., 2008",273,pregabalin: 150-600 mg/day,White,79,26,72.4,24.9,Pfizer Inc.,8,dsm-iv
"Montgomery et al., 2008",273,placebo,White,75,26,72.2,28.1,Pfizer Inc.,8,dsm-iv
